<code id='CFC9F66C14'></code><style id='CFC9F66C14'></style>
    • <acronym id='CFC9F66C14'></acronym>
      <center id='CFC9F66C14'><center id='CFC9F66C14'><tfoot id='CFC9F66C14'></tfoot></center><abbr id='CFC9F66C14'><dir id='CFC9F66C14'><tfoot id='CFC9F66C14'></tfoot><noframes id='CFC9F66C14'>

    • <optgroup id='CFC9F66C14'><strike id='CFC9F66C14'><sup id='CFC9F66C14'></sup></strike><code id='CFC9F66C14'></code></optgroup>
        1. <b id='CFC9F66C14'><label id='CFC9F66C14'><select id='CFC9F66C14'><dt id='CFC9F66C14'><span id='CFC9F66C14'></span></dt></select></label></b><u id='CFC9F66C14'></u>
          <i id='CFC9F66C14'><strike id='CFC9F66C14'><tt id='CFC9F66C14'><pre id='CFC9F66C14'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:5637
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Celiac disease study examines precisely how gluten triggers injury
          Celiac disease study examines precisely how gluten triggers injury

          AmicrographofCeliacdiseaseNephron/WikimediaCommonsForapersonwithceliacdisease,eatingabagelgoessometh

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Grail faces three suits alleging harassment, retaliation

          GrailThreesalesexecutives,allofthemwomen,havefiledsuitagainstGrail,acancerdiagnosticscompany,allegin